Comparison of antiplatelet regimens in secondary stroke prevention: a nationwide cohort study

BMC Neurology

Table 3 Predicted 1-year risk of ischemic stroke and bleeding based on Cox regression analysis

	Risk of ischemic stroke			Risk of bleeding
	3 months after stroke	6 months after stroke	12 months after stroke	3 months after stroke	6 months after stroke	12 months after stroke
Acetylsalicylic acid	3.6 [3.2; 4.0]	6.9 [6.3;7.7]	11.1 [10.2; 12.2]	1.2 [0.9; 1.4]	2.0 [1.6; 2.4]	3.4 [2.8; 3.9]
Acetylsalicylic acid and dipyridamole	2.4 [2.2; 2.7]	4.7 [4.4; 5.2]	7.7 [7.3; 8.3]	0.8 [0.7; 0.9]	1.4 [1.2; 1.6]	2.4 [2.1; 2.7]
Clopidogrel	2.5 [2.2; 2.9]	4.9 [4.3; 5.4]	8.0 [6.9; 8.7]	0.8 [0.6; 1.0]	1.4 [1.0; 1.7]	2.4 [1.9; 2.9]

The model was adjusted for sex, age, year, prior myocardial infarction, hypertension, diabetes, peripheral artery disease, heart failure, chronic obstructive lung disease, and cancer

ISSN: 1471-2377